Physician
Sulphur Pediatric Clinic Medical Corporation
Sulphur Pediatric Clinic Medical Corporation was paid $19.06M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoSULPHUR PEDIATRIC CLINIC MEDICAL CORPORATION
SULPHUR, LA 70663
SULPHUR, LA 70663
33aNPI1821042086assigned 05/20/2006
33bProvider typePediatrics Physician
28Total paid$19.06M
24GClaims642,806
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#5 of 230
Median peer was paid$429K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,260 | $2.80M | |
| 2019 | 89,883 | $2.71M | |
| 2020 | 65,391 | $1.94M | |
| 2021 | 80,760 | $2.43M | |
| 2022 | 101,768 | $2.95M | |
| 2023 | 112,376 | $3.19M | |
| 2024incomplete | 103,368 | $3.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 79,596 | 72,234 | $5.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 109,931 | 100,327 | $4.54M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.5% | 24,574 | 21,134 | $1.44M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.3% | 21,581 | 20,126 | $1.40M |
| 98960 | 5.4% | 14,597 | 9,971 | $1.03M | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 14,969 | 14,367 | $986K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.6% | 51,277 | 47,135 | $684K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 9,418 | 8,862 | $654K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.9% | 20,525 | 17,726 | $552K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.7% | 34,916 | 32,224 | $514K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 15,957 | 14,567 | $419K |
| 99051 | 1.6% | 15,916 | 14,755 | $299K |
76 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 13,944 | $251K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.1% | 8,101 | $201K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 16,493 | $132K |
| 92551 | <1% | 13,939 | $108K | |
| 99188 | <1% | 5,203 | $92K | |
| 90474 | <1% | 10,422 | $86K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,295 | $68K |
| 83655 | <1% | 7,596 | $68K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 830 | $56K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,037 | $55K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 852 | $43K |
| 99460 | <1% | 983 | $43K | |
| 54150 | <1% | 337 | $42K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 462 | $29K |
| 99173 | <1% | 13,792 | $25K | |
| 87634 | <1% | 557 | $21K | |
| 95117 | <1% | 1,915 | $17K | |
| 87807 | <1% | 1,671 | $17K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 196 | $17K |
| 96161 | <1% | 3,981 | $15K | |
| 85018 | <1% | 7,242 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,192 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,913 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 626 | $11K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 57 | $9K |
| 90837 | Psychotherapy session, about an hour | <1% | 132 | $8K |
| 0071A | <1% | 171 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 580 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 85 | $6K |
| 0072A | <1% | 111 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 60 | $5K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 40 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 206 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 46 | $3K |
| 0001A | <1% | 55 | $3K | |
| 0002A | <1% | 52 | $2K | |
| 81025 | <1% | 466 | $2K | |
| 36416 | <1% | 17,374 | $2K | |
| 96380 | <1% | 75 | $1K | |
| 99382 | <1% | 31 | $995.53 | |
| 99383 | <1% | 12 | $992.04 | |
| 99381 | <1% | 14 | $915.48 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 108 | $742.35 |
| 99441 | <1% | 32 | $326.03 | |
| 81003 | <1% | 183 | $247.07 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 23 | $200.72 |
| 90716 | <1% | 1,803 | $134.98 | |
| 90785 | <1% | 26 | $79.12 | |
| 96127 | <1% | 96 | $9.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 559 | $1.74 |
| 90651 | <1% | 3,699 | $0.16 | |
| 90633 | <1% | 10,578 | $0.12 | |
| 90671 | <1% | 6,277 | $0.04 | |
| 90710 | <1% | 1,929 | $0.01 | |
| 90700 | 0% | 2,256 | $0.00 | |
| 90670 | 0% | 12,331 | $0.00 | |
| 90734 | 0% | 1,826 | $0.00 | |
| 90621 | 0% | 637 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 78 | $0.00 |
| 90707 | 0% | 1,708 | $0.00 | |
| 90648 | 0% | 1,258 | $0.00 | |
| 91300 | 0% | 142 | $0.00 | |
| 90715 | 0% | 1,106 | $0.00 | |
| 90685 | 0% | 937 | $0.00 | |
| 90661 | 0% | 68 | $0.00 | |
| 90744 | 0% | 4,584 | $0.00 | |
| 90697 | 0% | 4,841 | $0.00 | |
| 90696 | 0% | 1,733 | $0.00 | |
| 90698 | 0% | 7,056 | $0.00 | |
| 90686 | 0% | 7,358 | $0.00 | |
| 90680 | 0% | 10,459 | $0.00 | |
| 90619 | 0% | 1,211 | $0.00 | |
| 99000 | 0% | 5,362 | $0.00 | |
| 91307 | 0% | 326 | $0.00 | |
| 90674 | 0% | 2,795 | $0.00 | |
| 90381 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHERT, ALBERT (CO/OWNER)